BOB体育

Skip to main content
(352) 265-0820

Mohammed Ruzieh, MD

Cardiologist (Heart Specialist)

Photo of Mohammed Ruzieh
(352) 265-0820 MyUFHealth

Research at a glance

Top areas of exploration

  • Postural Orthostatic Tachycardia Syndrome , 7 publications
  • Pulmonary Embolism , 6 publications
  • Cardiovascular Diseases , 5 publications
  • Biomarkers , 4 publications

Research activity

71 publications

359 citations

Why is this important?

Active clinical trials

Librexia AF

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.

Investigator
Mohammed Ruzieh
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

71 publications

2025

Additive Value of Right Ventricular Global Longitudinal Strain to a Conventional Echocardiographic Parameter to Improve Prognostic Value in Intermediate-Risk Pulmonary Embolism.

Journal of the American Heart Association

鈥�

2025

Association Between Use of WATCHMAN Device and 1-Year Mortality Using High-Dimensional Propensity Scores to Reduce Confounding

Circulation: Cardiovascular Quality and Outcomes

2025

Patients' lives don't pause for blanking periods.

American heart journal plus : cardiology research and practice

鈥�

2025

Trends in syncope testing and admissions in the USA from 2006 through 2019

Clinical Autonomic Research

2024

Association between right ventricular global longitudinal strain and mortality in intermediate-risk pulmonary embolism.

Echocardiography (Mount Kisco, N.Y.)

鈥�